Literature DB >> 7509341

Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

C A Cartwright1, C A Coad, B M Egbert.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with a high incidence of colon cancer. Dysplasia is a precursor to carcinoma and a predictor of malignant potential; epithelia containing high-grade or severe dysplasia is most likely to develop cancer. The cellular oncogene c-src and its viral homologue v-src (the transforming gene of Rous sarcoma virus) encode 60-kD cytoplasmic, membrane-associated protein tyrosine kinases. For the viral protein or transforming mutants of the cellular protein (Src), a close correlation exists between elevated tyrosine kinase activity and malignant transformation of cells. Previously, we and others observed elevated Src activity in sporadic colon carcinomas and benign adenomas at greatest risk for developing cancer (those with large size, villous architecture, and/or severe dysplasia). Here we report that Src activity and protein abundance are also elevated in neoplastic UC epithelia. Activity is highest in malignant and severely dysplastic epithelia, and 6-10-fold higher in mildly dysplastic than in nondysplastic epithelia. Thus, Src activity is elevated in premalignant UC epithelia, which is at greatest risk for developing cancer. The data suggest that activation of the src proto-oncogene is an early event in the genesis of UC colon cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509341      PMCID: PMC293871          DOI: 10.1172/JCI117000

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.

Authors:  N Rosen; J B Bolen; A M Schwartz; P Cohen; V DeSeau; M A Israel
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

3.  Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen.

Authors:  C A Cartwright; P L Kaplan; J A Cooper; T Hunter; W Eckhart
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

4.  Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.

Authors:  C A Cartwright; M A Hutchinson; W Eckhart
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

5.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

6.  A tail of two src's: mutatis mutandis.

Authors:  T Hunter
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

7.  Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders.

Authors:  P J Ciclitira; J C Macartney; G Evan
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

8.  Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.

Authors:  J A Cooper; F S Esch; S S Taylor; T Hunter
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

9.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses.

Authors:  L A Lipsich; A J Lewis; J S Brugge
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

10.  Activation of pp60c-src protein kinase activity in human colon carcinoma.

Authors:  J B Bolen; A Veillette; A M Schwartz; V DeSeau; N Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more
  26 in total

1.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 2.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

3.  Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion.

Authors:  Oxana M Tsygankova; Changqing Ma; Waixing Tang; Christopher Korch; Michael D Feldman; Yu Lv; Marcia S Brose; Judy L Meinkoth
Journal:  Mol Cell Biol       Date:  2010-05-03       Impact factor: 4.272

Review 4.  An Update on Surveillance in Ulcerative Colitis.

Authors:  Jimmy K Limdi; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2018-03-07

5.  Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.

Authors:  Elizabeth M Poole; Karen Curtin; Li Hsu; Richard J Kulmacz; David J Duggan; Karen W Makar; Liren Xiao; Christopher S Carlson; Martha L Slattery; Bette J Caan; John D Potter; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2011-12-03

6.  Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma.

Authors:  Jeff Yi-Fu Chen; Chih-Chang Hung; Kai-Lieh Huang; Yi-Ting Chen; Shyun-Yeu Liu; Wei-Fan Chiang; Hau-Ren Chen; Ching-Yu Yen; Yu-Jen Wu; Jenq-Yuh Ko; Yuh-Shan Jou
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 7.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

8.  SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling.

Authors:  M A Westhoff; B Serrels; V J Fincham; M C Frame; N O Carragher
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration.

Authors:  Sijo Mathew; Sudeep P George; Yaohong Wang; Mohammad Rizwan Siddiqui; Kamalakkannan Srinivasan; Langzhu Tan; Seema Khurana
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

10.  Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer.

Authors:  Earl Gillespie; Susan E Leeman; Luisa A Watts; Jennifer A Coukos; Michael J O'Brien; Sandra R Cerda; Francis A Farraye; Arthur F Stucchi
Journal:  J Crohns Colitis       Date:  2012-08-23       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.